Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

152.27 -1.13 (-0.74%)
Streaming Delayed Price Updated: 9:35 AM EDT, May 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
94 95 Next >
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
Kenvue says rewarding shareholders is an important part of its strategy. 
Via The Motley Fool
Is Kenvue Stock Too Pricey to Buy?
Its valuation depends on its brands being highly valuable indefinitely. 
Via The Motley Fool
3 Magnificent Dividend Stocks to Buy in October
These stocks come with great dividends and more. 
Via The Motley Fool
Recession-Proof Royals: 3 Stocks That Thrive in Tough Economic Times
Are you looking to invest in recession-proof stocks? Here are three stocks that thrive in tough economic times. 
Via InvestorPlace
Don’t Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP.
Dividend stocks have proven themselves over time to outperform non-paying stocks so it's smart to buy them when they go on sale. 
Via InvestorPlace
These 7 Dividend Stocks Pay $98 Billion Annually, Combined, to Their Shareholders
Seven brand-name, time-tested businesses are doling out between $11.2 billion and $22.3 billion to their shareholders each year. 
Via The Motley Fool
Looking At Johnson & Johnson's Recent Unusual Options Activity
Via Benzinga
(JNJ) - Analyzing Johnson & Johnson's Short Interest
Via Benzinga
Johnson & Johnson Unusual Options Activity
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs
AstraZeneca Plc (NASDAQ: AZN), Bristol Myers Squibb & Co (NYSE: BMY), and Boehringer Ingelheim are willing to participate in the initial round of Medicare drug price negotiation 
Via Benzinga
What's Going On Pfizer's Subsidiary Biohaven Stock?
Pfizer Inc's (NYSE: PFE) subsidiary Biohaven Ltd (NYSE: BHVN) released an  
Via Benzinga
Why Immunovant Stock Is Bolting Higher Today
The company may have best-in-class autoimmune disease therapy under its roof. 
Via The Motley Fool
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs
U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria.  More than a million people worldwide succumb to infections caused... 
Via Benzinga
3 Things About Johnson & Johnson That Smart Investors Know
J&J shares have missed out on the market rally so far this year. 
Via The Motley Fool
2 Monster Stocks to Buy Without Any Hesitation
Recent bumps in the road won't deter these companies. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Incredibly Cheap Dividend Stocks to Buy Now
High-quality dividend stocks are rarely cheap. These two names are an exception. 
Via The Motley Fool
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
Market crashes are inevitable, but certain stocks could limit potential damage. 
Via The Motley Fool
3 No-Brainer Stocks to Buy With $500 Right Now
A modest amount of money can go a long way when it's invested in industry-leading businesses. 
Via The Motley Fool
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
Discover how these seven standout companies offer both security and growth potential in an uncertain financial landscape. 
Via InvestorPlace
3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income
These companies generate durable and growing cash flows. 
Via The Motley Fool
3 Great Dividend Stocks You Can Buy for Less Than $50
These steady-Eddie operators are perfect bedrock stocks for investors despite trading for less than $50. 
Via The Motley Fool
Sandoz Pushes Product Launch Plans As Novartis Shareholders Approve The Spin-Off
At an Extraordinary General Meeting, Novartis AG's (NYSE: NVS) shareholders  
Via Benzinga
The 3 Most Undervalued Dow Stocks to Buy in September 2023
These undervalued Dow stocks have multiple, strong and positive catalysts and are poised to deliver strong returns for investors. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Lawsuit Against Dummy Pills For Allergy, Cold: Johnson & Johnson And Procter & Gamble Face Allegations
In a recent lawsuit, Johnson & Johnson (NYSE: JNJ) and Procter & Gamble Co (NYSE: PG) are facing allegations of misleading consumers regarding decongestant cold medicines conta 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
3 Blue-Chip Stocks to Watch in the ‘Green Zone’
Now may be the time to take a look at these three blue-chips, as each one is currently in the "Green Zone stocks" category. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
3 Warren Buffett Stocks That Are Near Their 52-Week Lows
Should you consider loading up on these stocks? 
Via The Motley Fool
Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains
Unearth the three best healthcare stocks to buy that are poised for long-term growth ahead for savvy investors. 
Via InvestorPlace
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
94 95 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.